Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Elevase is a multi-enzyme dietary supplement formulated to support and enhance the digestion of various macromolecules found in food. It comprises a blend of 13 enzymes, including alpha-galactosidase, amylase, beta-glucanase, cellulase, diastase, endopeptidase complex, exopeptidase complex, glucoamylase, invertase, lactase, lipase, protease, and xylanase, which are derived from microbial sources such as Aspergillus, Trichoderma, Saccharomyces, Candida, and Bacillus. This enzymatic composition enables the breakdown of complex carbohydrates, proteins, and fats into smaller, more absorbable nutrients, thereby accelerating the digestive process and potentially improving nutrient availability. Studies have indicated its efficacy in enhancing protein hydrolysis, gluten breakdown, and carbohydrate digestion, leading to increased levels of monosaccharides like glucose and fructose. Elevase is administered orally in capsule form.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Elevase.